<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7337927</article-id>
    <article-id pub-id-type="pmid">32463457</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkaa398</article-id>
    <article-id pub-id-type="publisher-id">gkaa398</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>Narese/7</subject>
        <subject>Narese/24</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Methods Online</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PolyA-miner: accurate assessment of differential alternative poly-adenylation from 3′Seq data using vector projections and non-negative matrix factorization</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Yalamanchili</surname>
          <given-names>Hari Krishna</given-names>
        </name>
        <aff><institution>Department of Molecular and Human Genetics, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Alcott</surname>
          <given-names>Callison E</given-names>
        </name>
        <aff><institution>Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Program in Developmental Biology, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Medical Scientist Training Program, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ji</surname>
          <given-names>Ping</given-names>
        </name>
        <aff><institution>Department of Biochemistry &amp; Molecular Biology, University of Texas Medical Branch</institution>, Galveston, TX, 77555, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wagner</surname>
          <given-names>Eric J</given-names>
        </name>
        <aff><institution>Department of Biochemistry &amp; Molecular Biology, University of Texas Medical Branch</institution>, Galveston, TX, 77555, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zoghbi</surname>
          <given-names>Huda Y</given-names>
        </name>
        <aff><institution>Department of Molecular and Human Genetics, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Howard Hughes Medical Institute</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Department of Pediatrics, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Department of Neuroscience, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7608-0831</contrib-id>
        <name>
          <surname>Liu</surname>
          <given-names>Zhandong</given-names>
        </name>
        <!--zhandong.liu@bcm.edu-->
        <aff><institution>Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <aff><institution>Department of Pediatrics, Baylor College of Medicine</institution>, Houston, TX 77030, <country country="US">USA</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 832 824 8878; Fax: +1 832 825 1251; Email: <email>zhandong.liu@bcm.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>09</day>
      <month>7</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-05-28">
      <day>28</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>28</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <volume>48</volume>
    <issue>12</issue>
    <fpage>e69</fpage>
    <lpage>e69</lpage>
    <history>
      <date date-type="accepted">
        <day>04</day>
        <month>5</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>05</day>
        <month>4</month>
        <year>2020</year>
      </date>
      <date date-type="received">
        <day>09</day>
        <month>9</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Almost 70% of human genes undergo alternative polyadenylation (APA) and generate mRNA transcripts with varying lengths, typically of the 3′ untranslated regions (UTR). APA plays an important role in development and cellular differentiation, and its dysregulation can cause neuropsychiatric diseases and increase cancer severity. Increasing awareness of APA’s role in human health and disease has propelled the development of several 3′ sequencing (3′Seq) techniques that allow for precise identification of APA sites. However, despite the recent data explosion, there are no robust computational tools that are precisely designed to analyze 3′Seq data. Analytical approaches that have been used to analyze these data predominantly use proximal to distal usage. With about 50% of human genes having more than two APA isoforms, current methods fail to capture the entirety of APA changes and do not account for non-proximal to non-distal changes. Addressing these key challenges, this study demonstrates PolyA-miner, an algorithm to accurately detect and assess differential alternative polyadenylation specifically from 3′Seq data. Genes are abstracted as APA matrices, and differential APA usage is inferred using iterative consensus non-negative matrix factorization (NMF) based clustering. PolyA-miner accounts for all non-proximal to non-distal APA switches using vector projections and reflects precise gene-level 3′UTR changes. It can also effectively identify novel APA sites that are otherwise undetected when using reference-based approaches. Evaluation on multiple datasets—first-generation MicroArray Quality Control (MAQC) brain and Universal Human Reference (UHR) PolyA-seq data, recent glioblastoma cell line <italic toggle="yes">NUDT21</italic> knockdown Poly(A)-ClickSeq (PAC-seq) data, and our own mouse hippocampal and human stem cell-derived neuron PAC-seq data—strongly supports the value and protocol-independent applicability of PolyA-miner. Strikingly, in the glioblastoma cell line data, PolyA-miner identified more than twice the number of genes with APA changes than initially reported. With the emerging importance of APA in human development and disease, PolyA-miner can significantly improve data analysis and help decode the underlying APA dynamics.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Prevention Research Institute of Texas</institution>
            <institution-id institution-id-type="DOI">10.13039/100004917</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>RP170387</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Houston Endowment</institution>
            <institution-id institution-id-type="DOI">10.13039/100001174</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Chao endowment</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Huffington foundation</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Howard Hughes Medical Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000011</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>NRI Zoghbi Scholar Award</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>NIH</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institute of Neurological Disorders and Stroke</institution>
            <institution-id institution-id-type="DOI">10.13039/100000065</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>F30NS095449</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institute of General Medical Sciences</institution>
            <institution-id institution-id-type="DOI">10.13039/100000057</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R01-GM134539</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Cancer Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000054</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R03-CA223893</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="12"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Advances in sequencing techniques have improved our understanding of the transcriptome and unraveled new mechanisms of complex diseases. However, several critical aspects of transcriptome diversity are underexplored. In the mRNA maturation process, the 3′end of precursor mRNA (pre-mRNA) is cleaved and a poly(A) sequence is added. In eukaryotes, all pre-mRNA molecules except histones undergo polyadenylation (<xref rid="B1" ref-type="bibr">1</xref>). In humans, ∼70% of genes undergo alternative polyadenylation (APA), where they can be cleaved at different sites on the 3′ end, generating mRNA transcripts of varying lengths (<xref rid="B2" ref-type="bibr">2</xref>). ∼50% of human genes have three or more polyadenylation sites (<xref rid="B3" ref-type="bibr">3</xref>). Multiple studies have demonstrated the pivotal role of alternative polyadenylation in key biological processes including gene regulation (<xref rid="B2" ref-type="bibr">2</xref>), mRNA localization (<xref rid="B4" ref-type="bibr">4</xref>), cell proliferation (<xref rid="B5" ref-type="bibr">5</xref>), differentiation (<xref rid="B6" ref-type="bibr">6</xref>), and senescence (<xref rid="B7" ref-type="bibr">7</xref>). The importance of alternative polyadenylation is also demonstrated in the development and prognosis of various oncological, neurological, immunological, and endocrinal diseases (<xref rid="B8" ref-type="bibr">8</xref>).</p>
    <p>Expressed sequence tags (EST) (<xref rid="B9" ref-type="bibr">9</xref>) were initially used to map polyadenylation sites. Later on, microarray and paired-end ditag (PET) approaches were used to detect global APA changes (<xref rid="B10" ref-type="bibr">10</xref>). But it was the next-generation sequencing (NGS) technology that started to transform APA analysis. RNA-Seq offers single-base resolution and a wider detection range in identifying novel genes, splice forms and non-coding transcripts. However, because of the huge intrinsic variation of read coverage at the 3′ end, precise mapping and quantification of polyadenylation sites is not possible. When looking at mapped reads, shorter 3′ UTR transcripts are undetectable unless they are expressed at dramatically higher levels than the longer isoforms. The increasing significance of APA in disease coupled with the limitations of traditional RNA-Seq propelled the development of several 3′RNA-seq techniques specifically designed to identify the mRNA cleavage and polyadenylation sites. These methods include 3′Seq, polyadenylation sequencing (PA-seq) and poly(A) site sequencing (PAS-seq), all of which use oligo(dT) primer based reverse transcription to capture the 3′ end of mRNA (Figure <xref rid="F1" ref-type="fig">1a</xref>). However, they all suffer from significant poor base-calling quality and mispriming, where the poly(dT) primer that is intended to bind the poly(A) tail instead binds a sequence of genomic adenines (<xref rid="B11" ref-type="bibr">11</xref>). Techniques like poly(A)-test RNA-sequencing (PAT-seq) and poly(A)-position profiling (3P-seq) try to minimize mispriming by adding adapters prior to primer annealing, but require complex RNA manipulation steps and perform poorly in quantification (<xref rid="B3" ref-type="bibr">3</xref>). Limiting factors like poly(A) enrichment and 3′ linker ligation steps are bypassed by Poly(A)-ClickSeq (PAC-seq) using click-chemistry (<xref rid="B12" ref-type="bibr">12</xref>), which can also be used for differential expression analysis (<xref rid="B13" ref-type="bibr">13</xref>)</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Illustration of PolyA-miner pipeline: (<bold>A</bold>) Raw 3′Seq reads. (<bold>B</bold>) Alignment. (<bold>C</bold>) Quantification of APA peaks: PA1 and PA2 are polyadenylation sites 1 and 2 respectively. (<bold>D</bold>) Identifying novel APA sites: NS1 and NS2 are novel polyadenylation sites that are not reported in PolyA_DB. (<bold>E</bold>) Denoising data: cleaning misprimed sites and noisy APA peaks. (<bold>F</bold>) Normalized APA matrix: each row is a polyadenylation site and columns are the read proportions in respective CR (control) and KD knockdown replicates. (<bold>G</bold>) Vector projection module to compute differential APA magnitude. (<bold>H</bold>) iterative consensus non-negative matrix factorization (NMF) module. (<bold>I</bold>) Modeling co-clustering frequencies. (<bold>J</bold>) Goodness of fit test of cluster membership over a null model. (<bold>K</bold>) Tracks showing detected APA changes.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398fig1" position="float"/>
    </fig>
    <p>With the explosion of emerging technologies, we need new analytical methods. In spite of increasing significance of APA and 3′ sequencing (3′Seq) techniques, there are no computational tools that are designed precisely for 3′Seq data. Several studies have analyzed conventional RNA-seq data to infer alternative polyadenylation changes. DaPars (<xref rid="B14" ref-type="bibr">14</xref>) uses a fisher exact test on proximal to distal APA site differences. Similarly, QAPA (<xref rid="B15" ref-type="bibr">15</xref>) uses DEXseq (<xref rid="B16" ref-type="bibr">16</xref>) and TAPAS (<xref rid="B17" ref-type="bibr">17</xref>) uses a change point strategy to infer APA changes from regular RNA-seq. However, none of them are 3′Seq specific and do not identify and account for all APA isoforms. Although previous studies have revealed the core insights from 3′seq data, their analyses have largely been incomplete. Those approaches typically either relied on existing poly-A annotations and ignored novel APA sites or were limited to proximal and distal polyadenylation sites (<xref rid="B18" ref-type="bibr">18</xref>) and ignored APA changes involving intermediate poly(A) sites (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>). Enrichment of proximal or distal polyadenylation sites, commonly referred to as proximal to distal usage (PDU) or distal to primal usage (DPU), are computed to infer gene level APA changes (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>). With almost 50% of genes having more than two polyadenylation sites, gene level APA changes are better comprehended by accounting for all polyadenylation sites. However, none of the existing approaches abstract all polyadenylation sites in quantifying gene level APA changes. The absolute lack of 3′Seq specific approaches strongly advocate the need for new computational methods to accurately assimilate the merits of 3′Seq data.</p>
    <p>Here, we propose PolyA-miner, a novel <italic toggle="yes">de novo</italic> differential alternative polyadenylation detection algorithm based on non-negative matrix factorization (NMF) (<xref rid="B20" ref-type="bibr">20</xref>) and vector projections. NMF is popularly used for feature extraction in image processing (<xref rid="B21" ref-type="bibr">21</xref>). It is also successfully used to elucidate (factorize) gene expression patterns (<xref rid="B22" ref-type="bibr">22</xref>). It provides an intuitive interpretation of the factorization and parts-based, local representation in contrast to other well-known methods (<xref rid="B23" ref-type="bibr">23</xref>). The current context of alternative polyadenylation (APA) changes is analogues to clustering gene expression patterns where polyadenylation sites are represented as rows and samples as columns. NMF is a good fit when the attributes are ambiguous or have weak predictability (<xref rid="B24" ref-type="bibr">24</xref>). This is advantageous to account for all polyadenylation (polyA) sites with no single dominant polyA site. PolyA-miner tests how well the unsupervised consensus clustering of an APA matrix agrees with the ground truth (class labels). Co-clustering frequencies from iterative NMF are modeled as a beta distribution and the statistical significance of APA change is evaluated by the goodness-of-fit of the consensus clustering over a null model. Differential APA magnitude is computed as the difference of APA vector projections on to the most distal APA site in an <italic toggle="yes">n-</italic>dimensional vector space, where <italic toggle="yes">n</italic> is the number of APA sites. The methodical flow of PolyA-miner is illustrated in Figure <xref rid="F1" ref-type="fig">1</xref>. PolyA-miner is evaluated with both the first generation MAQC brain and UHR PolyA-seq data (<xref rid="B3" ref-type="bibr">3</xref>), on recent Glioblastoma cell line <italic toggle="yes">NUDT21</italic> knock down PAC-seq (3′Seq) data (<xref rid="B19" ref-type="bibr">19</xref>), and our own mouse hippocampal and human stem cell-derived neuron PAC-seq data. A detailed description of the proposed approach is given in the following Materials and Methods section.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Processing raw reads</title>
      <p>Irrespective of sequencing protocol nucleotide composition is biased at the beginning of reads due to random hexamer priming while amplifying cDNA (<xref rid="B25" ref-type="bibr">25</xref>). To improve the mappability (<xref rid="B26" ref-type="bibr">26</xref>), the first six nucleotides (<xref rid="B12" ref-type="bibr">12</xref>) and adapter contamination is filtered out using fastp (<xref rid="B27" ref-type="bibr">27</xref>). To minimize ambiguous alignment, reads &lt;40 bp are also filtered out. Raw reads are then mapped to the reference genome of origin using bowtie2 (<xref rid="B28" ref-type="bibr">28</xref>). Alignment files in <italic toggle="yes">‘sam’</italic> format are converted to <italic toggle="yes">‘bam’</italic>, sorted and indexed using samtools (<xref rid="B29" ref-type="bibr">29</xref>).</p>
    </sec>
    <sec id="SEC2-2">
      <title>De novo extraction of alternative polyadenylation sites</title>
      <p>All potential sample-wise poly adenylation (polyA) sites are extracted from alignment files as per base coverage features/peaks using the genomecov module in bedtools (Figure <xref rid="F1" ref-type="fig">1C</xref>). A comprehensive library of polyadenylation sites is computed by pooling all sample-wise feature files. To account for any intrinsic limitations in sequencing protocols, polyA sites that overlap or are within a minimal distance <italic toggle="yes">md</italic> are merged (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2e</xref>). Parameter <italic toggle="yes">md</italic> can be adjusted based on polyA resolution supported by the respective sequencing protocol used. Since 3′ sequencing methods use poly(dT) primers—to bind the mRNA poly(A) tail—they can also bind stretches of adenines within the body of the mRNA, resulting in sequencing reads that do not align with the cleavage site (<xref rid="B30" ref-type="bibr">30</xref>). We call these misprimed reads. Such misprimed sites are computationally filtered by exploring the downstream base composition (<xref rid="B31" ref-type="bibr">31</xref>). Typically, sites with greater than 15nt out of 20 nucleotides (75%) are considered false positives (<xref rid="B12" ref-type="bibr">12</xref>). However, here we took a more conservative approach: each mapped polyA site is extended towards the 3′ end by a mispriming distance <italic toggle="yes">mpd</italic> and scanned for a genomic PolyA feature. Sites with &gt;65% of adenines in a sliding window of 20 bp are filtered out as shown in Figure <xref rid="F1" ref-type="fig">1E</xref>. Sites within 50 bp of an annotated cleavage site (<xref rid="B32" ref-type="bibr">32</xref>) are considered accurate regardless of the percentage of adjacent adenines.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Mapping, denoising and normalizing APA counts</title>
      <p>After filtering out misprimed sites, resulting polyA sites are mapped to their respective genes. Often times novel polyA sites fall beyond the annotated gene boundary. Because the longest known 3′UTR is 16 kilobases (kb) (<xref rid="B33" ref-type="bibr">33</xref>), APA sites are mapped to genes if they are within this distance of their respective transcriptional end site (TES) and do not overlap with any other gene (illustrated in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2a</xref>). Sample-wise polyA site counts are computed as the total number of reads mapped to the respective polyA site intervals using featureCounts (<xref rid="B34" ref-type="bibr">34</xref>). Each gene is conceptualized as a matrix with APA sites as rows and sample replicates as columns. To restrict the untoward effect of sequencing noise, polyA sites failing the pOverA function are filtered out. This function evaluates whether the proportion of replicates larger than A (reads) exceeds p with a minimum of <italic toggle="yes">M</italic> reads per site in at least one test group (illustrated in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2b</xref>). APA matrix is further pruned by filtering out the sites that fall short of a minimum proportion <italic toggle="yes">mp</italic> of total reads mapped to the respective gene in both the conditions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2c</xref>). To constrain the APA changes due to non-expressed genes, genes with less than a minimum expression count <italic toggle="yes">me</italic> in either of the conditions are filtered out (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2d</xref>).</p>
    </sec>
    <sec id="SEC2-4">
      <title>Iterative Consensus non-negative matrix factorization (NMF)</title>
      <p>PolyA-miner uses iterative consensus clustering to detect alternative polyadenylation changes (Figure <xref rid="F1" ref-type="fig">1H</xref>). Typically, clustering techniques are used to group samples or data points. However, in the current context of differential alternative polyadenylation, we have <italic toggle="yes">a priori</italic> information of sample clustering, i.e., a specified set of control and treated samples. The key here is to test the agreement between the clustering consensus of an APA matrix and the ground truth of a priori sample labels, which is essentially a factorization problem. Non-negative matrix factorization (NMF) is an unsupervised clustering paradigm that has previously been demonstrated for multivariate decomposition (<xref rid="B35" ref-type="bibr">35</xref>). Given an <italic toggle="yes">m</italic> x <italic toggle="yes">n</italic> dimensional non-negative APA matrix <italic toggle="yes">V</italic>, where <italic toggle="yes">m</italic> is the number of APA sites and <italic toggle="yes">n</italic> is the number of samples, we factorize <italic toggle="yes">V</italic> into an <italic toggle="yes">n</italic> × <italic toggle="yes">k</italic> matrix <italic toggle="yes">W</italic> and a <italic toggle="yes">k</italic> × <italic toggle="yes">m</italic> matrix <italic toggle="yes">H</italic> such that: <italic toggle="yes">V<sub>m</sub></italic><sub>×</sub><italic toggle="yes"><sub>n</sub> ≈ W<sub>n</sub></italic><sub>×</sub><italic toggle="yes"><sub>k</sub> H<sub>k</sub></italic><sub>×</sub><italic toggle="yes"><sub>m</sub></italic>, where <italic toggle="yes">k</italic> is the number of clusters. In our example, we have two clusters: control and treated (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3a</xref>). Factorization is approximated by minimizing the cost function (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3a–c</xref>):<disp-formula><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}F(W,H)\, = \,\left\| {V - WH} \right\|_F^2\end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>We used an efficient Coordinate Descent method (<xref rid="B36" ref-type="bibr">36</xref>) to solve <italic toggle="yes">W</italic> and <italic toggle="yes">H</italic>. Cluster membership is inferred from the <italic toggle="yes">H</italic> matrix, a sample is assigned to a cluster <italic toggle="yes">i</italic> if <italic toggle="yes">H<sub>i,m</sub> &gt; H<sub>j,m</sub></italic>. detailed account of NMF is described elsewhere (<xref rid="B37" ref-type="bibr">37</xref>). Initialization can introduce potential bias in NMF (<xref rid="B38" ref-type="bibr">38</xref>). To minimize this, we execute NMF iteratively (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3d</xref>) and infer a robust dichotomization (control versus treated). An <italic toggle="yes">n</italic> x <italic toggle="yes">n</italic> co-clustering consensus matrix <italic toggle="yes">CM</italic> is computed (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3e</xref>) from the independent iterative NMF runs, where <italic toggle="yes">n</italic> is the number of samples.<disp-formula><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} {C{M_{i,j}}} = \left\{\begin{matrix} 1\quad if\;i = j\\[4pt] {{C_{ij|k}}/ni}\\[4pt] 0\quad if\;i &gt; j \end{matrix}\right. \end{eqnarray*}$$\end{document}</tex-math></disp-formula></p>
      <p><italic toggle="yes">CM<sub>i,j</sub></italic> is the co-clustering frequency of samples <italic toggle="yes">i</italic> and <italic toggle="yes">j</italic>. <italic toggle="yes">C<sub>ij|k</sub></italic> is the number of time sample <italic toggle="yes">i</italic> and <italic toggle="yes">j</italic> are assigned to the <italic toggle="yes">a priori</italic> cluster <italic toggle="yes">k</italic> and <italic toggle="yes">ni</italic> is the number of NMF iterations.</p>
    </sec>
    <sec id="SEC2-5">
      <title>Modeling beta distribution and likelihood-ratio (LRT) test</title>
      <p>Co-clustering frequencies from iterative NMF are modeled using a beta distribution (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3f</xref>). Beta distribution is widely used to model outcomes that are constrained within a defined interval [0 to 1] and two parameters α, β, controlling the distribution shape. The probability density function (pdf) of a random variable <italic toggle="yes">X</italic> following beta distribution, <italic toggle="yes">X∼Beta(α,β)</italic> is given by:<disp-formula><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} P(x) &amp;=&amp; \frac{{{x^{\alpha - 1}}{{\left( {1 - x} \right)}^{\beta - 1}}}}{{B\left( {\alpha ,\beta } \right)}}\\ &amp;=&amp;\left\{\begin{array}{ll} \frac{{{\rm{\Gamma }}\left( {\alpha + \beta } \right)}}{{{\rm{\Gamma }}\left( \alpha \right){\rm{\;\Gamma }}\left( \beta \right)}}{{\left( {1 - x} \right)}^{\beta - 1}}\;{x^{\alpha - 1}} &amp; \quad if\;0\; \le x \le 1\\[4pt] 0 &amp; \quad else \end{array}\right. \end{eqnarray*}$$\end{document}</tex-math></disp-formula>where <italic toggle="yes">α</italic> &gt; 0, <italic toggle="yes">β</italic> &gt; 0 and <inline-formula><tex-math id="M4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Gamma \;}}( a ) = \mathop \smallint \nolimits_0^{ + \infty } {x^{a - 1}}\;{e^{ - x}}\;dx$\end{document}</tex-math></inline-formula> The mean and variance of a beta distribution are given by:<disp-formula><tex-math id="M5">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}\bar x \approx \,\frac{\alpha }{{\alpha + \beta }};\,\,\,\,\,{s^2} \approx \frac{{\alpha \beta }}{{{{(\alpha + \beta )}^2}(\alpha + \beta + 1)}}\end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>We model co-clustering frequencies from CM matrix as a beta distribution. The parameters <italic toggle="yes">α,β</italic> are estimated using the moments method.<disp-formula><tex-math id="M6">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}\beta = \frac{{\alpha (1 - \bar x)}}{{\bar x}};\,\,\,\,\alpha = \bar x\left[ {\frac{{\bar x(1 - \bar x)}}{{{s^2}}} - 1} \right]\end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>The log likelihood function of a beta model measure how well they fit the underlying data and is given by:<disp-formula><tex-math id="M7">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}L\left( {\alpha ,\beta } \right) = \mathop \sum \limits_{i = 1}^N {\rm{log}}\left( {\frac{{{\rm{\Gamma }}\left( {\alpha + \beta } \right)}}{{{\rm{\Gamma }}\left( \alpha \right){\rm{\;\Gamma }}\left( \beta \right)}}\;{x^{\alpha - 1}}{{\left( {1 - x} \right)}^{\beta - 1}}} \right)\end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>Three sets of parameters and respective likelihoods are estimated for intra-group <italic toggle="yes">L</italic>(<italic toggle="yes">α</italic><sub>1</sub>,<italic toggle="yes">β</italic><sub>1</sub>) and inter-group <italic toggle="yes">L</italic>(<italic toggle="yes">α</italic><sub>2</sub>,<italic toggle="yes">β</italic><sub>2</sub>) and null <italic toggle="yes">L</italic>(<italic toggle="yes">α</italic><sub>0</sub><italic toggle="yes">,β</italic><sub>0</sub>). Intra-group likelihood is modelled on the co-clustering frequencies of samples with the same <italic toggle="yes">a priori</italic> condition (control or treated), the inter-group likelihood is modeled on the co-clustering frequencies of samples from different conditions (control and treated), and a null distribution is modelled on the whole <italic toggle="yes">CM</italic> matrix. Differential polyadenylation is tested by evaluating the goodness-of-fit of the respective intra-group and inter-group co-clustering frequencies over the null model. A likelihood ratio test statistic is computed as the ratio of a simpler null model <italic toggle="yes">s</italic> to a complex alternative model <italic toggle="yes">g</italic>.<disp-formula><tex-math id="M8">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} {{\rm LRT}} &amp;=&amp; - 2{\log_{\rm e}}({L_{\rm s}}/{L_g})\\ &amp;=&amp; - 2{\log_{\rm e}}({L_s}/{L_{\rm g}})\\ &amp;=&amp; - 2({L_0} - \left( {{L_1} + {L_2}} \right)) \end{eqnarray*}$$\end{document}</tex-math></disp-formula>where L1, L2 and L0 are intra group, inter group and null model log likelihoods. LRT statistic is approximated as a χ<sup>2</sup> distribution with 2 degrees of freedom and the <italic toggle="yes">P</italic> value is computed accordingly (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3g</xref>).</p>
    </sec>
    <sec id="SEC2-6">
      <title>Magnitude of alternative polyadenylation (APA) change</title>
      <p>Genes undergoing polyadenylation changes often have more than two APA sites (<xref rid="B3" ref-type="bibr">3</xref>) and the changes are not always at the most distal and most proximal cleavage sites. The ideal magnitude metric should reflect changes at all APA sites that affect 3′UTR length. Vector projection is a good means to quantify a multi-dimensional variable (w.r.t a reference). An intuitive way to understand a projection of a vector <italic toggle="yes">u</italic> on vector <italic toggle="yes">v</italic> is the shadow of vector <italic toggle="yes">u</italic> on vector <italic toggle="yes">v</italic> (illustrated in in Figure <xref rid="F4" ref-type="fig">4A</xref>).<disp-formula><tex-math id="M9">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}\left\| {pro{j_v}\vec u} \right\| = \left\| {\frac{{\vec u{\rm{\;}}{{\rm{\;}}^.}{\rm{\;}}\vec v}}{{{{\left\| {{{\vec v}^2}} \right\|}^2}}}{\rm{\;}}\vec v} \right\|{\rm{\;}} = \frac{{\left\| {\vec u{\rm{\;}}{{\rm{\;}}^.}{\rm{\;}}\vec v} \right\|}}{{\left\| {{{\vec v}^2}} \right\|}}{\rm{\;\;\;}}\left\| {{{\vec v}^2}} \right\| = \frac{{\left| {\vec u{\rm{\;}}{{\rm{\;}}^.}{\rm{\;}}\vec v} \right|}}{{\left\| {{{\vec v}^2}} \right\|}}\end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>Projection of the most proximal or distal APA site effectively resonate 3′UTR shrinking or lengthening respectively. Control and treated APA matrices are vectorized by a row mean operation and the magnitude of APA change is computed as the difference in projections of respective APA vectors on to the most proximal APA site in an <italic toggle="yes">n</italic> dimensional vector space, where <italic toggle="yes">n</italic> is the number of APA sites. Genes with higher distal projections in controls over treated are predicted as 3′UTR shortening and vice versa as illustrated in Figure <xref rid="F4" ref-type="fig">4B</xref>.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS AND DISCUSSION</title>
    <sec id="SEC3-1">
      <title>Plethora of misprimed and noisy APA sites are filtered by PolyA-miner</title>
      <p>A majority of 3′Sequencing datasets suffer from misidentification of spurious and noisy APA sites due to oligo (dT) internal priming of polyadenine stretches within the body of mRNA rather than the poly(A) tail. To evaluate the ability of PolyA-miner to filter misprimed sequencing reads, we applied our method to the Glioblastoma (GBM) LN229 cell line <italic toggle="yes">NUDT21</italic> knock down (KD) PAC-Seq data (SRP172550). This dataset is first reported in Chu <italic toggle="yes">et al.</italic> (2019) and was generated to help elucidate the contribution of <italic toggle="yes">NUDT21</italic> dependent APA regulation in GBM progression. We examined several genes that showed high levels of mispriming. Seven alternative polyadenylation (APA) sites are annotated for the gene ATRX in PolyA_DB, a database of APA sites backed by sequencing evidence (<xref rid="B32" ref-type="bibr">32</xref>). PolyA-miner detected 30 APA sites in the zoomed-in region shown for <italic toggle="yes">ATRX</italic> (Figure <xref rid="F2" ref-type="fig">2A</xref>) including 23 new putative novel sites. Out of the 23 putative sites PolyA-miner filtered out 19 putative sites with &gt;65% of genomic adenines in a sliding window of 20 bp as described in the methods. A representative misprimed site with genomic poly thymine stretch (in negative sense strand) is annotated in Figure <xref rid="F2" ref-type="fig">2A</xref>. Furthermore, three of the four putative sites retained after mispriming filter and three of the seven annotated APA sites are filtered out by pOverA and other de-noising filters (Figure <xref rid="F2" ref-type="fig">2A</xref>). Similarly, we detected five out of six and three out of four misprimed putative sites in the genes <italic toggle="yes">PAK2</italic> and <italic toggle="yes">IDS</italic> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2e and d</xref>). In addition, out of the seven PolyA_DB annotated sites in IDS, three are dropped by denoising filters. At the transcriptome level, 212 366 of the total 255 055 identified putative APA sites are potentially misprimed (Figure <xref rid="F2" ref-type="fig">2B</xref>), a remarkable 83%. De-noising pOverA and proportion filters dropped 17 253 novel and 27 615 annotated APA sites that are inconsistent across respective replicates. Furthermore, the gene expression filter dropped 13 765 novel and 5325 annotated sites to control for non-expressed genes in either of the conditions.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>(<bold>A</bold>) Illustration of mispriming and other noise levels in the gene ATRX from <italic toggle="yes">NUDT21</italic> KD PAC-Seq data. Lane 1 shows all extracted polyA sites from the zoomed in region: Shown in blue are annotated sites from PolyA_DB and shown in black are putative sites. Highlighted in box is a representative misprimed site. Lane 2 shows polyA site that are flagged by different Poly-miner filters: Shown in grey are misprimed sites and shown in green are flagged by de-noising filters. Marked with tick (✓) are the retained polyA to test for APA changes. Distribution of the filtered putative and annotated APA sites by respective de-noising filters in (<bold>B</bold>) <italic toggle="yes">NUDT21</italic> KD PAC-Seq data and (<bold>C</bold>) MAQC brain-UHR PolyA-seq data.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398fig2" position="float"/>
      </fig>
      <p>To thoroughly understand the noise levels in 3′ UTR sequencing data by ruling out any technical or species bias, we generated our own 3′Seq data from wild type mouse hippocampi and human stem cell-derived neurons (Supplementary methods). Both the mouse and human data had significantly high levels of mispriming and noise (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S4a and b</xref>), similar to previous <italic toggle="yes">NUDT21</italic> knock down PAC-seq data (Figure <xref rid="F2" ref-type="fig">2B</xref>). These observations demonstrate the high levels of false positive polyA site identification inherent to 3′ sequencing and substantiate the merit of PolyA-miner to properly mine and interpret 3′ sequencing data. Our data is uploaded to GEO and will be a useful resource for investigating various technical aspects of 3′Seq data and better understanding the transcriptome of those tissues.</p>
    </sec>
    <sec id="SEC3-2">
      <title>More than twice the number of APA changes are identified in <italic toggle="yes">NUDT21</italic> knock down PAC-seq data than initially reported</title>
      <p>APA vector projections are more proximal (less distal) in <italic toggle="yes">NUDT21</italic> KD samples than controls, suggesting global 3′UTR shortening (Figure <xref rid="F3" ref-type="fig">3A</xref>). This observation is in agreement with previously published analyses (<xref rid="B19" ref-type="bibr">19</xref>). However, the study reported only 695 genes with APA changes. PolyA-miner identified a striking 1562 genes with APA changes, revealing extensive APA dynamics (Figure <xref rid="F3" ref-type="fig">3A</xref> and <xref rid="F3" ref-type="fig">B</xref>). To evaluate the methodological merit in an un-biased setup, consistent mispriming and denoising filters are applied to both the distal to proximal usage (DPU) and PolyA-miner. Annotated polyA sites from polyA_DB are used to control for novel APA site discovery advantage of PolyA-miner. As the executable code is not available for a direct comparison of the DPU approach with PolyA-miner, we repeated the analysis (supplementary methods). The DPU approach detected 921 genes with 3′UTR shortening and 16 with elongation (Adjusted <italic toggle="yes">P</italic> value ≤ 0.05). Among them, 844 (92%) and 14 were also detected by PolyA-miner with a total of 1504 3′UTR shortening and 58 3′UTR elongation changes (Figure <xref rid="F3" ref-type="fig">3B</xref>), including <italic toggle="yes">VMA21</italic>, a well-established positive control gene reported in previous <italic toggle="yes">NUDT21</italic> KD studies. The complete list of detected APA changes by PolyA-miner and DPU approach are given in <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S1 and S2</xref> respectively. These data show that PolyA-miner replicates the results of previous methods and expands them.</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>(<bold>A</bold>) PolyA-miner reveals extensive 3′UTR shortening in LN299 Glioblastoma <italic toggle="yes">NUDT21</italic> knock down data: Size of the marker indicate statistical significance. Color gradient (red to orange) indicate 3′UTR length long to short. (<bold>B</bold>) Overlap and discordance of PolyA-miner and DPU predictions. (<bold>C</bold>) APA heatmap of genes with two polyadenylations that are predicted to be 3′UTR shortening only by PolyA-miner. (<bold>D</bold>) NUDT21 motif frequency in genes that are predicted to be 3′UTR shortening by PolyA-miner. (<bold>E</bold>) Phenotype analysis of PolyA-miner results. (<bold>F</bold>) Clustering stability of PolyA-miner and DPU only predictions. (<bold>G</bold> and <bold>H</bold>) Tracks showing 3′UTR shortening identified by both PolyA-miner and DPU, and only PolyA-miner. (<bold>I</bold> and <bold>J</bold>) APA proportion matrices of the genes shown in (G) and (H) respectively.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398fig3" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-3">
      <title>Concordant APA patterns strongly substantiate novel PolyA-miner predictions</title>
      <p>PolyA-miner predicted 660 3′UTR shortened genes that are missed by DPU (Figure <xref rid="F3" ref-type="fig">3B</xref>). These hits are grouped by the number of APA sites in the visual illustration. The heatmap of the genes with two APA sites suggest conclusive 3′UTR shrinking (Figure <xref rid="F3" ref-type="fig">3C</xref>). Striking dark blue (low) to light blue (high) and contrariwise light red (high) to dark red (low) patterns are observed at the proximal and distal polyadenylation sites between control and <italic toggle="yes">NUDT21</italic> KD samples respectively. This high proximal and low distal pattern in <italic toggle="yes">NUDT21</italic> KD samples illustrate 3′UTR shortening. Genes with three APA sites also show similar apparent differential usage patterns at the proximal (blue: low to high) and distal (green: high to low) sites (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5</xref>). Together, two and three APA site genes constitute 466 (70%) of PolyA-miner only predictions. Heatmaps of 4 and 5 APA genes are also shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5</xref>.</p>
      <p>Additionally, to further substantiates PolyA-miner predictions, we explored the distribution of the NUDT21 binding motif in the predicted targets. Earlier studies showed that NUDT21 binds to UGUA motif and reported global 3′UTR shrinking with a significant enrichment of the UGUA motifs near the distal polyA sites compared to the proximal polyA sites in Nudt21 knockdown models (<xref rid="B18" ref-type="bibr">18</xref>). In agreement with previous reports, we found an enrichment of the UGUA binding motif frequency upstream of the distal cleavage site in the genes that showed significant 3′ UTR shortening after <italic toggle="yes">NUDT21</italic> loss (Figure <xref rid="F3" ref-type="fig">3D</xref>). In contrast, no difference in UGUA motif distribution was found between proximal and distal polyA sites of the genes with no APA changes or lengthened (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6</xref>). This observation supports the model that NUDT21 is directed to distal sites to facilitate polyadenylation and thereby corroborate novel PolyA-miner APA predictions.</p>
      <p>We next examined the clustering stability scores (described in supplementary methods) of the discordant predictions, i.e. the hits that are only predicted by either PolyA-miner or DPU. High clustering stability is observed for PolyA-miner only predictions (Figure <xref rid="F3" ref-type="fig">3F</xref>) with a median stability score of 0.73 over DPU only predictions (of 0.51). Obvious differential APA patterns (Figure <xref rid="F3" ref-type="fig">3C</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5</xref>), enrichment of UGUA motif (Figure <xref rid="F3" ref-type="fig">3D</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6</xref>), and high clustering stability (Figure <xref rid="F3" ref-type="fig">3F</xref>) strongly substantiate the validity of PolyA-miner novel predictions.</p>
    </sec>
    <sec id="SEC3-4">
      <title>PolyA-miner competently reveal non-distal or non-proximal APA dynamics</title>
      <p>To understand the methodological advantages of PolyA-miner, we examined the genes that are consistent between PolyA-miner and DPU and respective novel predictions. The APA shift from the most distal to the most proximal site in the gene <italic toggle="yes">TUSC2</italic> (Figure <xref rid="F3" ref-type="fig">3G</xref>) is detected by both PolyA-miner and DPU. The APA proportion matrix also confirms the same (Figure <xref rid="F3" ref-type="fig">3I</xref>). With just one source-sink (distal-proximal) pair, such changes in general are simpler to identify. However, in the gene <italic toggle="yes">UBTF</italic> (Figure <xref rid="F3" ref-type="fig">3H</xref>) the alternative polyadenylation switch from the most distal polyadenylation site (PA) 3 to the intermediate sites (PA2) is predicted only by PolyA-miner. The vector projection metric of PolyA-miner can effectively reflect changes at all APA sites as described in the methods section. On the other hand, the DPU approach computes only distal to proximal usage, ignoring all other non-proximal to non-distal changes. The APA proportion matrix also show decrease in PA3 and increase in PA2 proportions in <italic toggle="yes">NUDT21</italic> KD samples (Figure <xref rid="F3" ref-type="fig">3J</xref>). This conclusively support PolyA-miner prediction. A significant fraction, about 33% of the genes with APA changes in <italic toggle="yes">NUDT21</italic> KD PAC-Seq data are not distal to proximal changes. This strongly demonstrates the merit of PolyA-miner in identifying broader APA dynamics. The DPU method did predict some candidate genes that PolyA-miner did not. For example, it predicted differential APA usage in the gene <italic toggle="yes">GNS</italic> whereas PolyA-miner did not. However, the sample variability and low consensus clustering stability score (0.47) makes it less likely to be true. One of the <italic toggle="yes">NUDT21</italic> KD sample is as high as controls at the most distal site and is significantly distant from the other two replicates (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S7a and S7b</xref>; high variable sites are annotated with stars). PolyA-miner penalizes such debatable predictions with the intra and inter clustering frequency-based beta statistic.</p>
    </sec>
    <sec id="SEC3-5">
      <title>PolyA-miner 3′UTR score accurately reflects gene level 3′UTR shortening</title>
      <p>Typical differential analyses rank respective hits by mere fold change, but this is not appropriate for APA changes. For example, the gene <italic toggle="yes">MAPK1</italic> the distal site is drifted to the most proximal sites (Figure <xref rid="F4" ref-type="fig">4C</xref>). The proximal site PA1 is increased by 4.5-fold in <italic toggle="yes">NUDT21</italic> KD samples. On the other hand, in the gene EGFR distal sites are shifted to an intermediate site with 4.7-fold increase (Figure <xref rid="F4" ref-type="fig">4D</xref>). Just by the magnitude of fold change at PA2 <italic toggle="yes">EGFR</italic> ranks higher to MAPK1. However, the proportion of transcripts with the most proximal PA site (shortest 3UTR) is high in <italic toggle="yes">MAPK1</italic>. Shorter the 3′UTR a transcript is more likely to lose miRNA binding sites and less likely to be down regulated. With the shortest dominant isoform <italic toggle="yes">MAPK1</italic> (Figure <xref rid="F4" ref-type="fig">4C</xref>) is more likely to have stronger downstream effect when compared to <italic toggle="yes">EGFR</italic> (Figure <xref rid="F4" ref-type="fig">4D</xref>) with second shortest dominant isoform. Thus, in the context of 3′UTR shortening/elongation, the ranking metric should reflect both magnitude and position of APA (3′UTR length) changes. Using vector projections (described in methods) PolyA-miner can account for both the position and magnitude of change. PolyA-miner scoring aptly suggests an overall greater shortening effect in <italic toggle="yes">MAPK1</italic> (−0.29) over <italic toggle="yes">EGFR</italic> (−0.11). This ranking is critical for any downstream analysis that takes rank as their input, such as Gene Set Enrichment Analysis (GSEA).</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Accurate assessment of 3′UTR shortening/elongation using vector projections: (<bold>A</bold>) Projection of vector <italic toggle="yes">u</italic> on <italic toggle="yes">v</italic>. (<bold>B</bold>) Illustration of 3′UTR changes. Shown in blue is 3′UTR shrinking with control distal projection is greater than that of treated. Conversely, shown in red is 3′UTR elongation with treated distal projection is greater than that of control. Shown in green is when control distal projection is equal to that of treated indicating no change in 3′UTR. (<bold>C</bold>) APA switch from most distal (PA4) to most proximal site (PA1) in MAPK1 and (<bold>D</bold>) APA switch from switch PA4 to PA2 in EGFR.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398fig4" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-6">
      <title>PolyA-miner predictions translate to biological insights</title>
      <p>Phenotype analysis of PolyA-miner predicted genes with 3′UTR shortening showed enrichment for intellectual disability, neurodevelopmental delays and other neuropsychiatric phenotypes (Figure <xref rid="F3" ref-type="fig">3E</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>). These align with the recent advances in <italic toggle="yes">NUDT21</italic> biology (<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>). On the other hand, phenotype enrichment of DPU predictions is limited (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S7c, Table S4</xref>). Furthermore, in <italic toggle="yes">de-novo</italic> APA site detection mode, PolyA-miner identified 3074 novel polyadenylation sites that were otherwise not reported in PolyA_DB (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S5</xref>).</p>
    </sec>
    <sec id="SEC3-7">
      <title>Widespread longer 3′UTR isoforms are observed in MAQC human brain PolyA-seq data</title>
      <p>To demonstrate the protocol independent usability of PolyA-miner, we next evaluated it with MAQC Universal Human Reference (UHR) and human brain PolyA-seq datasets (<xref rid="B3" ref-type="bibr">3</xref>). PolyA-seq is one of the first generation 3′ sequencing protocols and requires complex polyA enrichment, sample preparation and purification steps (<xref rid="B12" ref-type="bibr">12</xref>). Data was obtained from the GEO database (GSM747473-76). Similar to <italic toggle="yes">NUDT21</italic> KD PAC-Seq data, ∼94% of the putative APA sites are filtered out by mispriming and other de-noising filters (Figure <xref rid="F2" ref-type="fig">2c</xref>). This reinforces our conclusion about the magnitude of internal priming events and noise in the current 3′Sequencing protocols. In <italic toggle="yes">de-novo</italic> APA site detection mode, PolyA-miner identified 21338 novel polyadenylation sites (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S10</xref>). Predominantly distal polyA sites (longer 3′UTR isoforms) are found in human brain, i.e. APA vector projections are more distal in brain when compared to that of UHR (Figure <xref rid="F5" ref-type="fig">5A</xref>). This observation is consistent with the literature (<xref rid="B33" ref-type="bibr">33</xref>).</p>
      <fig position="float" id="F5">
        <label>Figure 5.</label>
        <caption>
          <p>(<bold>A</bold>) PolyA-miner reveals extensive 3′UTR elongation in MAQC brain and UHR PolyA-seq data: Size of the marker indicate statistical significance. Color gradient (red to orange) indicate 3′UTR length long to short. (<bold>B</bold>) Overlap and discordance of PolyA-miner and DPU predictions. (<bold>C</bold>) APA heatmap of genes with two polyadenylations and (<bold>D</bold>) 3 polyadenylations sites. (<bold>E</bold>) Functional analysis of PolyA-miner prediction (GO terms with FDR ≤ 0.05). (<bold>F</bold> and <bold>G</bold>) Tracks showing 3′UTR elongations identified by both PolyA-miner and DPU, and only. Distal APA sites (elongation) is annotated with arrows and corresponding RNASeq tracks are also shown. (<bold>H</bold> and <bold>I</bold>) APA proportion matrices of the genes shown in F and G respectively.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398fig5" position="float"/>
      </fig>
      <p>PolyA-miner identified 2441 3′UTR elongated and 366 shortened genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S6</xref>). The DPU approach identified 367 3′UTR elongation and 42 3′UTR shrinking events (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S7</xref>), out of which 356 and 36 events are also detected by PolyA-miner (Figure <xref rid="F5" ref-type="fig">5B</xref>). On the other hand, PolyA-miner predicted 2085 and 330 elongations and shortening events that are not detected by DPU. APA heatmap patterns illustrated in Figure <xref rid="F5" ref-type="fig">5C</xref>, <xref rid="F5" ref-type="fig">D</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8</xref> conclusively validate PolyA-miner novel predictions. PolyA-miner elongation predictions are enriched for RNA splicing, mRNA processing, post translational regulation, (Figure <xref rid="F5" ref-type="fig">5E</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S8</xref>) which aligns with the high transcriptional and splicing diversity in the brain (<xref rid="B41" ref-type="bibr">41</xref>). Functional insights from DPU predictions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9c and Table S9</xref>) are limited when compared to that of PolyA-miner predictions.</p>
      <p>Both PolyA-miner and DPU predicted 3′UTR elongation in the gene <italic toggle="yes">ANKH</italic> (Figure <xref rid="F5" ref-type="fig">5f</xref>). APA proportion matrix (Figure <xref rid="F5" ref-type="fig">5H</xref>) and standard RNASeq of samples obtained from Sequencing Quality Control (SEQC) project also suggest dominant distal polyadenylation site in brain (annotated by an arrow in Figure <xref rid="F5" ref-type="fig">5F</xref>). However, only PolyA-miner predicted 3′UTR elongation in the gene <italic toggle="yes">DPH3</italic> (Figure <xref rid="F5" ref-type="fig">5G</xref>). Both regular RNASeq tracks (Figure <xref rid="F5" ref-type="fig">5G</xref>) and APA proportion matrix (Figure <xref rid="F5" ref-type="fig">5I</xref>) validate PolyA-miner predictions. There is an increase in proportion of the distal sites PA4 and PA3 in brain samples. On the other hand, only DPU predicted 3′UTR elongation in the gene <italic toggle="yes">RIOK1</italic> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9a</xref>). APA proportions (reads) from both proximal and distal sites are redistributed to the intermediate site (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9b</xref>) making this a debatable prediction. It essentially boils down to change magnitude vs APA site position (length). A detailed experimental investigation is necessary to establish an agreement between the APA position (length) and the magnitude of change to assess the downstream effect.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC4">
    <title>CONCLUSION</title>
    <p>PolyA-miner is the first differential alternative polyadenylation usage tool that is specifically designed for 3′Seq data. We demonstrated the importance of extensive filtering in pre-processing 3′Seq data. Further, our iterative consensus NMF makes the analysis less susceptible to intra sample variation. Most importantly, using vector projections, PolyA-miner can account for all APA changes including non-proximal to non-distal changes and can distinguish the most distal to most proximal changes from most distal to intermediate site changes irrespective of absolute change magnitude. This sensitivity is extremely important to thoroughly estimate of the true breadth of 3′UTR shortening and elongation. Evaluation on both the first generation MAQC brain and UHR PolyA-seq data, and recent Glioblastoma cell line PAC-seq (3′Seq) data strongly supports the value and protocol independent applicability of PolyA-miner. We demonstrated a substantial increase in both the number of dynamic APA events detected and novel APA sites using PolyA-miner. With the emerging importance of alternative polyadenylation in understanding development and diseases, PolyA-miner can significantly improve data analysis and help decode the missing pieces of underlying alternative polyadenylation dynamics.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>PolyA-miner is implemented in Python and the source code is freely available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.liuzlab.org/PolyA-miner/" ext-link-type="uri">http://www.liuzlab.org/PolyA-miner/</ext-link>. The PAC-seq data are available in the NCBI Gene Expression Omnibus (GEO), accession number: GSE147661.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkaa398_Supplemental_Files</label>
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkaa398_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank the members of the Liu and Zoghbi labs for helpful discussions and suggestions. We would also like to thank the Human Neuronal Differentiation core from the Jan and Dan Duncan Neurological Research Institute and the Next Generation Sequencing core at the University of Texas Medical Branch.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkaa398#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>Cancer Prevention Research Institute of Texas [RP170387 to Z.L.]; Houston endowment, Chao endowment, Huffington foundation (to Z.L.); Howard Hughes Medical Institute (to H.Y.Z.); NRI Zoghbi Scholar Award (to H.K.Y.); NIH, National Institute of Neurological Disorders and Stroke [F30NS095449 to C.E.A.]; NIH, National Institute of General Medical Sciences [R01-GM134539 to E.J.W.]; NIH, National Cancer Institute [R03-CA223893-01 to P.J.]. Funding for open access charge: Cancer Prevention and Research Institute of Texas [RP170387].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erson-Bensan</surname><given-names>A.E.</given-names></string-name></person-group><article-title>Alternative polyadenylation and RNA-binding proteins</article-title>. <source>J. Mol. Endocrinol.</source><year>2016</year>; <volume>57</volume>:<fpage>F29</fpage>–<lpage>F34</lpage>.<pub-id pub-id-type="pmid">27208003</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erson-Bensan</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Can</surname><given-names>T.</given-names></string-name></person-group><article-title>Alternative polyadenylation: another foe in cancer</article-title>. <source>Mol. Cancer Res.</source><year>2016</year>; <volume>14</volume>:<fpage>507</fpage>–<lpage>517</lpage>.<pub-id pub-id-type="pmid">27075335</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Derti</surname><given-names>A.</given-names></string-name>, <string-name><surname>Garrett-Engele</surname><given-names>P.</given-names></string-name>, <string-name><surname>MacIsaac</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Stevens</surname><given-names>R.C.</given-names></string-name>, <string-name><surname>Sriram</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>R.</given-names></string-name>, <string-name><surname>Rohl</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Babak</surname><given-names>T.</given-names></string-name></person-group><article-title>A quantitative atlas of polyadenylation in five mammals</article-title>. <source>Genome Res.</source><year>2012</year>; <volume>22</volume>:<fpage>1173</fpage>–<lpage>1183</lpage>.<pub-id pub-id-type="pmid">22454233</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tushev</surname><given-names>G.</given-names></string-name>, <string-name><surname>Glock</surname><given-names>C.</given-names></string-name>, <string-name><surname>Heumüller</surname><given-names>M.</given-names></string-name>, <string-name><surname>Biever</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jovanovic</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schuman</surname><given-names>E.M.</given-names></string-name></person-group><article-title>Alternative 3′ UTRs modify the localization, regulatory potential, stability, and plasticity of mRNAs in neuronal compartments</article-title>. <source>Neuron</source>. <year>2018</year>; <volume>98</volume>:<fpage>495</fpage>–<lpage>511</lpage>.<pub-id pub-id-type="pmid">29656876</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sandberg</surname><given-names>R.</given-names></string-name>, <string-name><surname>Neilson</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Sarma</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sharp</surname><given-names>P.A.</given-names></string-name>, <string-name><surname>Burge</surname><given-names>C.B.</given-names></string-name></person-group><article-title>Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites</article-title>. <source>Science</source>. <year>2008</year>; <volume>320</volume>:<fpage>1643</fpage>–<lpage>1647</lpage>.<pub-id pub-id-type="pmid">18566288</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tian</surname><given-names>B.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>B.</given-names></string-name></person-group><article-title>Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development</article-title>. <source>Proc. Natl Acad. Sci. U.S.A.</source><year>2009</year>; <volume>106</volume>:<fpage>7028</fpage>–<lpage>7033</lpage>.<pub-id pub-id-type="pmid">19372383</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Song</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>G.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>T.</given-names></string-name></person-group><article-title>Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence</article-title>. <source>Aging</source>. <year>2019</year>; <volume>11</volume>:<fpage>1356</fpage>–<lpage>1388</lpage>.<pub-id pub-id-type="pmid">30835716</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chang</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Yeh</surname><given-names>H.S.</given-names></string-name>, <string-name><surname>Yong</surname><given-names>J.</given-names></string-name></person-group><article-title>Alternative polyadenylation in human diseases</article-title>. <source>Endocrinol. Metab.</source><year>2017</year>; <volume>32</volume>:<fpage>413</fpage>–<lpage>421</lpage>.</mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gautheret</surname><given-names>D.</given-names></string-name>, <string-name><surname>Poirot</surname><given-names>O.</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Audic</surname><given-names>S.</given-names></string-name>, <string-name><surname>Claverie</surname><given-names>J.M.</given-names></string-name></person-group><article-title>Alternate polyadenylation in human mRNAs: A large-scale analysis by EST clustering</article-title>. <source>Genome Res.</source><year>1998</year>; <volume>8</volume>:<fpage>524</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">9582195</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ng</surname><given-names>P.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>J.J.S.</given-names></string-name>, <string-name><surname>Ooi</surname><given-names>H.S.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y.L.</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>K.P.</given-names></string-name>, <string-name><surname>Fullwood</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Srinivasan</surname><given-names>K.G.</given-names></string-name>, <string-name><surname>Perbost</surname><given-names>C.</given-names></string-name>, <string-name><surname>Du</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sung</surname><given-names>W.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Multiplex sequencing of paired-end ditags (MS-PET): A strategy for the ultra-high-throughput analysis of transcriptomes and genomes</article-title>. <source>Nucleic. Acids. Res.</source><year>2006</year>; <volume>34</volume>:<fpage>e84</fpage>.<pub-id pub-id-type="pmid">16840528</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>W.</given-names></string-name>, <string-name><surname>Jia</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Song</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Fu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>G.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>T.</given-names></string-name></person-group><article-title>Alternative polyadenylation: methods, findings, and impacts methods and findings of slternative polyadenylation</article-title>. <source>Genomics ProteomicsBioinformatics</source>. <year>2017</year>; <volume>15</volume>:<fpage>287</fpage>–<lpage>300</lpage>.</mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Routh</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>P.</given-names></string-name>, <string-name><surname>Jaworski</surname><given-names>E.</given-names></string-name>, <string-name><surname>Xia</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>E.J.</given-names></string-name></person-group><article-title>Poly(A)-ClickSeq: click-chemistry for next-generation 3′-end sequencing without RNA enrichment or fragmentation</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>e112</fpage>.<pub-id pub-id-type="pmid">28449108</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elroda</surname><given-names>N.D.</given-names></string-name>, <string-name><surname>Jaworski</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>P.</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Routh</surname><given-names>A.</given-names></string-name></person-group><article-title>Development of Poly(A)-ClickSeq as a tool enabling simultaneous genome-wide poly(A)-site identification and differential expression analysis</article-title>. <source>Methods</source>. <year>2019</year>; <volume>155</volume>:<fpage>20</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">30625385</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xia</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Donehower</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Neilson</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Wheeler</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.</given-names></string-name></person-group><article-title>Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′2-UTR landscape across seven tumour types</article-title>. <source>Nat. Commun.</source><year>2014</year>; <volume>5</volume>:<fpage>5274</fpage>.<pub-id pub-id-type="pmid">25409906</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ha</surname><given-names>K.C.H.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Morris</surname><given-names>Q.</given-names></string-name></person-group><article-title>QAPA: a new method for the systematic analysis of alternative polyadenylation from RNA-seq data</article-title>. <source>Genome Biol.</source><year>2018</year>; <volume>19</volume>:<fpage>45</fpage>.<pub-id pub-id-type="pmid">29592814</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anders</surname><given-names>S.</given-names></string-name>, <string-name><surname>Reyes</surname><given-names>A.</given-names></string-name>, <string-name><surname>Huber</surname><given-names>W.</given-names></string-name></person-group><article-title>Detecting differential usage of exons from RNA-seq data</article-title>. <source>Genome Research</source>. <year>2012</year>; <volume>22</volume>:<fpage>2008</fpage>–<lpage>2017</lpage>.<pub-id pub-id-type="pmid">22722343</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arefeen</surname><given-names>A.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>T.</given-names></string-name></person-group><article-title>TAPAS: Tool for alternative polyadenylation site analysis</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>2521</fpage>–<lpage>2529</lpage>.<pub-id pub-id-type="pmid">30052912</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brumbaugh</surname><given-names>J.</given-names></string-name>, <string-name><surname>Di Stefano</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Borkent</surname><given-names>M.</given-names></string-name>, <string-name><surname>Forouzmand</surname><given-names>E.</given-names></string-name>, <string-name><surname>Clowers</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>F.</given-names></string-name>, <string-name><surname>Schwarz</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Kalocsay</surname><given-names>M.</given-names></string-name>, <string-name><surname>Elledge</surname><given-names>S.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Nudt21 controls cell fate by connecting alternative polyadenylation to chromatin signaling</article-title>. <source>Cell</source>. <year>2018</year>; <volume>172</volume>:<fpage>106</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">29249356</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Elrod</surname><given-names>N.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Routh</surname><given-names>A.</given-names></string-name>, <string-name><surname>Xia</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>P.</given-names></string-name></person-group><article-title>Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients</article-title>. <source>Oncogene</source>. <year>2019</year>; <volume>38</volume>:<fpage>4154</fpage>–<lpage>4168</lpage>.<pub-id pub-id-type="pmid">30705404</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Dhillon</surname><given-names>I.S.</given-names></string-name>, <string-name><surname>Sra</surname><given-names>S.</given-names></string-name></person-group><article-title>Generalized nonnegative matrix approximations with Bregman divergences</article-title>. <source>Proceedings of the 18th International Conference on Neural Information Processing Systems</source>. <year>2005</year>; <fpage>283</fpage>–<lpage>290</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Buciu</surname><given-names>I.</given-names></string-name>, <string-name><surname>Pitas</surname><given-names>I.</given-names></string-name></person-group><article-title>Application of non-negative and local non negative matrix factorization to facial expression recognition</article-title>. <source>Proceedings - International Conference on Pattern Recognition</source>. <year>2004</year>; <volume>1</volume>:<fpage>288</fpage>–<lpage>291</lpage>.</mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brunet</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Tamayo</surname><given-names>P.</given-names></string-name>, <string-name><surname>Golub</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Mesirov</surname><given-names>J.P.</given-names></string-name></person-group><article-title>Metagenes and molecular pattern discovery using matrix factorization</article-title>. <source>Proc. Natl Acad. Sci. U.S.A.</source><year>2004</year>; <volume>101</volume>:<fpage>4164</fpage>–<lpage>4169</lpage>.<pub-id pub-id-type="pmid">15016911</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Donoho</surname><given-names>D.</given-names></string-name>, <string-name><surname>Stodden</surname><given-names>V.</given-names></string-name></person-group><article-title>When does non-negative matrix factorization give a correct decomposition into parts?</article-title>. <source>Advances in Neural Information Processing Systems</source>. <year>2004</year>; <publisher-loc>Columbia</publisher-loc><publisher-name>MIT Press</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Devarajan</surname><given-names>K.</given-names></string-name></person-group><article-title>Nonnegative matrix factorization: an analytical and interpretive tool in computational biology</article-title>. <source>PLoS Comput. Biol.</source><year>2008</year>; <volume>4</volume>:<fpage>e1000029</fpage>.<pub-id pub-id-type="pmid">18654623</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hansen</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Brenner</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Dudoit</surname><given-names>S.</given-names></string-name></person-group><article-title>Biases in Illumina transcriptome sequencing caused by random hexamer priming</article-title>. <source>Nucleic. Acids. Res.</source><year>2010</year>; <volume>38</volume>:<fpage>e131</fpage>.<pub-id pub-id-type="pmid">20395217</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Del Fabbro</surname><given-names>C.</given-names></string-name>, <string-name><surname>Scalabrin</surname><given-names>S.</given-names></string-name>, <string-name><surname>Morgante</surname><given-names>M.</given-names></string-name>, <string-name><surname>Giorgi</surname><given-names>F.M.</given-names></string-name></person-group><article-title>An extensive evaluation of read trimming effects on illumina NGS data analysis</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e85024</fpage>.<pub-id pub-id-type="pmid">24376861</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gu</surname><given-names>J.</given-names></string-name></person-group><article-title>Fastp: An ultra-fast all-in-one FASTQ preprocessor</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>i884</fpage>–<lpage>i890</lpage>.<pub-id pub-id-type="pmid">30423086</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="given-only"><given-names>Langmead</given-names></string-name>, <string-name><surname>Salzberg</surname><given-names>SL</given-names></string-name></person-group><article-title>Bowtie2</article-title>. <source>Nat. Methods</source>. <year>2013</year>; <volume>9</volume>:<fpage>357</fpage>–<lpage>359</lpage>.</mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Handsaker</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wysoker</surname><given-names>A.</given-names></string-name>, <string-name><surname>Fennell</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Homer</surname><given-names>N.</given-names></string-name>, <string-name><surname>Marth</surname><given-names>G.</given-names></string-name>, <string-name><surname>Abecasis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Durbin</surname><given-names>R.</given-names></string-name></person-group><article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2078</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nam</surname><given-names>D.K.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>G.</given-names></string-name>, <string-name><surname>Cao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>T.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rowley</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.M.</given-names></string-name></person-group><article-title>Oligo(dT) primer generates a high frequency of truncated cDNAs through internal poly(A) priming during reverse transcription</article-title>. <source>Proc. Natl Acad. Sci. U.S.A.</source><year>2002</year>; <volume>99</volume>:<fpage>6152</fpage>–<lpage>6156</lpage>.<pub-id pub-id-type="pmid">11972056</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Yeh</surname><given-names>I.</given-names></string-name>, <string-name><surname>Park</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>B.</given-names></string-name></person-group><article-title>PolyA_DB 2: mRNA polyadenylation sites in vertebrate genes</article-title>. <source>Nucleic. Acids. Res.</source><year>2007</year>; <volume>35</volume>:<fpage>D165</fpage>–<lpage>D168</lpage>.<pub-id pub-id-type="pmid">17202160</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Recce</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>B.</given-names></string-name></person-group><article-title>PolyA_DB: a database for mammalian mRNA polyadenylation</article-title>. <source>Nucleic. Acids. Res.</source><year>2005</year>; <volume>33</volume>:<fpage>D116</fpage>–<lpage>D120</lpage>.<pub-id pub-id-type="pmid">15608159</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miura</surname><given-names>P.</given-names></string-name>, <string-name><surname>Shenker</surname><given-names>S.</given-names></string-name>, <string-name><surname>Andreu-Agullo</surname><given-names>C.</given-names></string-name>, <string-name><surname>Westholm</surname><given-names>J.O.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>E.C.</given-names></string-name></person-group><article-title>Widespread and extensive lengthening of 39 UTRs in the mammalian brain</article-title>. <source>Genome Res.</source><year>2013</year>; <volume>23</volume>:<fpage>812</fpage>–<lpage>825</lpage>.<pub-id pub-id-type="pmid">23520388</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>G.K.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>W.</given-names></string-name></person-group><article-title>The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote</article-title>. <source>Nucleic. Acids. Res.</source><year>2013</year>; <volume>41</volume>:<fpage>e108</fpage>.<pub-id pub-id-type="pmid">23558742</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>C.</given-names></string-name></person-group><article-title>Non-negative matrix factorizations for clustering: a survey</article-title>. <source>Data Cluste.: Algorith. Applic.</source><year>2019</year>; <fpage>149</fpage>–<lpage>176</lpage>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hsieh</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Dhillon</surname><given-names>I.S.</given-names></string-name></person-group><article-title>Fast coordinate descent methods with variable selection for non-negative matrix factorization</article-title>. <source>Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining</source>. <year>2011</year>; <fpage>1064</fpage>–<lpage>1072</lpage>.</mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.J.</given-names></string-name></person-group><article-title>Nonnegative matrix factorization: a comprehensive review</article-title>. <source>IEEE Trans. Knowl. Data Eng.</source><year>2013</year>; <fpage>1336</fpage>–<lpage>1353</lpage>.</mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Grais</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Erdogan</surname><given-names>H.</given-names></string-name></person-group><article-title>Initialization of nonnegative matrix factorization dictionaries for single channel source separation</article-title>. <source>2013 21st Signal Processing and Communications Applications Conference, SIU 2013</source>. <year>2013</year>; </mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gennarino</surname><given-names>V.A.</given-names></string-name>, <string-name><surname>Alcott</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Chaudhury</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gillentine</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Rosenfeld</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Parikh</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wheless</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Roeder</surname><given-names>E.R.</given-names></string-name>, <string-name><surname>Horovitz</surname><given-names>D.D.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation</article-title>. <source>eLife</source>. <year>2015</year>; <volume>4</volume>:<fpage>e10782</fpage>.</mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alcott</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Yalamanchili</surname><given-names>H.K.</given-names></string-name>, <string-name><surname>Ji</surname><given-names>P.</given-names></string-name>, <string-name><surname>van der Heijden</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Saltzman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Elrod</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Leng</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bhatt</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation</article-title>. <source>eLife</source>. <year>(2020)</year>; <volume>9</volume>:<fpage>e50895</fpage>.<pub-id pub-id-type="pmid">32319885</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Raj</surname><given-names>B.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name></person-group><article-title>Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles</article-title>. <source>Neuron</source>. <year>2015</year>; <volume>87</volume>:<fpage>14</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">26139367</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
